Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
26.90
+0.60 (2.28%)
Jun 9, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Revenue
Pelthos Therapeutics had revenue of $10.91M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $27.70M. In the year 2025, Pelthos Therapeutics had annual revenue of $16.80M.
Revenue (ttm)
$27.70M
Revenue Growth
n/a
P/S Ratio
3.38
Revenue / Employee
$301,098
Employees
92
Market Cap
93.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.80M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Heron Therapeutics | 150.71M |
| Fortress Biotech | 66.16M |
| Cue Biopharma | 32.73M |
| ImmuCell | 29.93M |
| Cibus | 3.64M |
| Outlook Therapeutics | 333.14K |
| Inovio Pharmaceuticals | 65.34K |
PTHS News
- 12 days ago - Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 26 days ago - Pelthos Therapeutics price target raised to $66 from $62 at Oppenheimer - TheFly
- 26 days ago - Pelthos Therapeutics reports Q1 EPS ($3.58), consensus ($3.09) - TheFly
- 26 days ago - Pelthos Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 26 days ago - Pelthos Therapeutics Earnings release: Q1 2026 - Filings
- 26 days ago - Pelthos Therapeutics Quarterly report: Q1 2026 - Filings
- 27 days ago - Pelthos Therapeutics Announces First Quarter 2026 Financial Results - GlobeNewsWire
- 4 weeks ago - Pelthos Therapeutics Slides: Corporate presentation - Filings